US Patent Issued to HANMI PHARM. on Feb. 17 for "GLP-1/GIP dual agonist, long-acting conjugate thereof, and pharmaceutical composition comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,850, issued on Feb. 17, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"GLP-1/GIP dual agonist, long-acting conjugate thereof, and pharmaceutical composition comprising same" was invented by Eun Jung Kim (Hwaseong-si, South Korea), Jae Hyuk Choi (Hwaseong-si, South Korea), Nyeong Sang Yoo (Hwaseong-si, South Korea), Hyeon Joo Im (Hwaseong-si, South Korea) and Sang Hyun Lee (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a GLP-1/GIP dual agonist, a pharmaceutically acceptable salt thereof, a solvate thereof, or a long-acting conjugate thereof, or a pharmaceutical composition for preventing or tr...